This event has concluded. We will be exhibiting and presenting at the Cell Culture Medium Symposium at Shonan, held at Shonan Ai Park on September 13, 2024 (Friday). At our booth, we will introduce Sartorius's wide range of media, raw materials, and services that meet the needs of cell culture. *You can view the program in the "Related Materials." [Event Overview] Date and Time: September 13, 2024 (Friday) 10:00 AM - 5:45 PM Location: Shonan Ai Park or online *Pre-registration required [Our Seminar] Title: Recombumin | Enabling safe and robust manufacturing across various modalities with recombinant human albumin Speaker: Shiori Akiyama (Sales Development Specialist - Cell Lines, Media, Various Tests) Seminar Time: 3:40 PM - 4:10 PM Overview: This seminar will focus on Recombumin, a recombinant human albumin that improves cell viability after cryopreservation and has an effect on suppressing the aggregation of cells and vectors.

Participation in this webinar has ended. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. Adeno-associated virus (AAV) vectors are gaining attention for their excellent suitability as vectors in gene therapy. The production of AAV vectors commonly uses transient expression system HEK cells, but the examination of their culture and production conditions is complex and time-consuming. Additionally, there is no standardized process, and product-specific characterization and safety testing are required. In this webinar, we will outline the manufacturing and process development of AAV vectors, followed by an introduction to Sartorius' culture-related solutions, including HEK media that simplify media selection, comprehensive characterization covering key evaluation items, and cell bank production. [Seminar Overview] ▪ Date: September 28 (Thursday) from 3:00 PM (approximately 45 minutes) ▪ Format: Webinar recorded broadcast [Japanese, free of charge] *We apologize, but participation from companies in the same industry and email addresses other than those of your organization is not permitted. Thank you for your understanding.

This event has concluded. We will be exhibiting and presenting at the Cell Culture Medium Symposium at Shonan, held at Shonan Ai Park on September 13, 2024 (Friday). At our booth, we will introduce Sartorius's wide range of media, raw materials, and services that meet the needs of cell culture. *You can view the program in the "Related Materials." [Event Overview] Date and Time: September 13, 2024 (Friday) 10:00 AM - 5:45 PM Location: Shonan Ai Park or online *Pre-registration required [Our Seminar] Title: Recombumin | Enabling safe and robust manufacturing across various modalities with recombinant human albumin Speaker: Shiori Akiyama (Sales Development Specialist - Cell Lines, Media, Various Tests) Seminar Time: 3:40 PM - 4:10 PM Overview: This seminar will focus on Recombumin, a recombinant human albumin that improves cell viability after cryopreservation and has an effect on suppressing the aggregation of cells and vectors.

Participation in this webinar has ended. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. In the complex and variable field of biopharmaceutical development, screening for the optimal culture medium requires significant time and effort. The newly launched Sartorius media for CHO and HEK cells that we will introduce supports consistent production from research to manufacturing, with known chemical composition and free from animal-derived components. Additionally, it consists of multiple types of media and feeds, allowing you to select the optimal combination tailored to individual applications and conditions. In this seminar, we will provide information on the characteristics and performance of the media, as well as samples. *We apologize, but participation from email addresses other than those of your company or organization is not permitted. Thank you for your understanding.

Expectations for regenerative medicine using stem cells such as mesenchymal stem cells (MSC) and induced pluripotent stem cells (iPSC) are rising, but for industrialization, there is a need for technology to produce high-quality cells in large quantities and in a stable manner. In this seminar, we will introduce xenofree stem cell culture media that do not contain components derived from animals other than humans, as well as examples of 3D culture using our microcarriers, bioreactors, and experimental design software. We will also present HEK media used for immune cell culture media and lentivirus production as products for cell therapy, such as CAR-T. 【Seminar Overview】 ▪ Date: October 12 (Thursday) from 3:00 PM (approximately 30 minutes) ▪ Format: Webinar recorded broadcast [Japanese, Free] If you are unable to attend on the day, please register first. Later, we will send you a link to download the recorded video and related product materials. *We apologize, but participation from other companies in the same industry, as well as email addresses not associated with your organization, is not permitted. Thank you for your understanding.

The reception here has ended. Thank you for your registration. A must-see for those looking for solutions to the complex process development of gene therapy! The field of gene therapy has been receiving increasing attention in recent years, but its long and complex processes involve many considerations, requiring significant time and effort for optimization. At JAACT2022, our specialists will introduce solutions focused on process development using HEK293 cells. In the technical seminar at the venue, we will propose the latest technologies and solutions, including new products. Additionally, at our booth, we will showcase Sartorius's new products (HEK293 media sample kit | Ambr 250 perfusion) and hold demonstrations (MODDE | SIMCA). Technical Seminar Information Title: Challenges in New Modalities by Sartorius Date and Time: July 26 (Wednesday) 15:10 - 15:35 [Main Learning Content] ▪ Case study using microreactor systems (Ambr) ▪ Tools that can be used for scale-up ▪ HEK293 cell culture media system

Participation in this webinar has ended. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. Cellular immunotherapy has scientifically proven the efficacy of CAR-T cells in the treatment of blood cancers, and development is progressing globally. This has heightened interest in the scientific and medical communities and serves as a driving force to develop more effective and cost-efficient cellular immunotherapies. Therefore, the development of high-quality auxiliary materials such as culture media for cultivating these immune cells is crucial. To meet such needs, our company has developed the serum-free 4Cell Nutri-T Medium. Method of delivery: Webinar recorded broadcast (with Japanese subtitles, free of charge) *We sincerely apologize, but participation from email addresses other than those of your company or organization is not permitted. Thank you for your understanding.

Registration for this webinar has ended. Thank you for signing up. Sartorius will participate in the co-hosted seminar, "EthanCell Online Forum Technology Presentation Session - CPC Edition: Learning from CPC-related Companies about Various Products and Services for CPC Operations." This seminar aims to provide participants with the opportunity to learn about services and products suitable for each individual through seminars from companies in various fields related to CPC, contributing to the revitalization of regenerative medicine and research. Our company will introduce our media products used for cell culture under the title "Sartorius Media Supporting Robust and Consistent Cell Culture" starting at 14:25.